The Angel Capital Summit hosted by the Rockies Venture Club featured presentations from 38 companies as well as several speakers. Below are summaries of 10 of the presenting companies. RockyRadar will offer a second summary of companies on Wednesday:
mShopper offers a mobile commerce platform including an ad platform, merchant services and its PriceCrusher application for consumers. Through PriceCrusher, consumers can perform price comparisons, make purchases and initiate reverse auctions all via SMS messaging. The company boasts 85K subscribers to its Get First Dibs program, which sends customers alerts of merchant offers. Most services are free to customers while merchants and advertisers pay fees. The company is currently seeking funds to accelerate customer acquisition.
ConferenceEdge provides logistics management for both live and online events as well as for other business types including online training and education. The company provides a scalable and stable product that is platform agnostic, allowing users to integrate with a variety of technologies for other meeting related functions (e.g. WebEx). The system is better suited to complex events compared to some of the more basic online competitors.
BioCare Systems Inc makes the LumiWave device which uses infrared light to accelerate healing. Infrared light enhances healing by triggering nitric oxide release which enhances blood and lymph flow and through direct stimulation of the cell healing process. The device may be able to speed both bone and muscle healing as well as to re-grow cartilage. BioCare has attacked the sports injury market first and was used by several US teams at the Olympics and by several professional and collegiate teams. The device is portable and currently costs $499. BioCare expects unit costs and prices to fall when it offshores and expands production with its next round of funding.
SpyderLynk provides a system to make advertising in offline media both interactive and trackable. Advertisers include a snap tag – the brand’s logo surrounded a circle that contains breaks, which allow the company to specifically indentify the tag – within an advertisement. Users then send a photo of this tag via SMS or email to receive a response from the advertiser (e.g. bonus content, coupon). The tags can be used with almost any media, from magazines to billboards to t-shirts. SpyderLynk, which was founded in 2006 and has run 40 campaigns with national brands, is seeking funding to build out a SaaS platform for its product.
St Renatus takes the needle out of the equation when a dental procedure requires local anesthetic. The company is able to deliver anesthetic nasally, using the same applicators currently used by Flumist. An additional advantage of this approach is that numbness does not occur in other the mouth. The company uses a very old molecule, Tetracaine, but has patents around the delivery and uses that stretch until 2022. The company has successfully completed Phase 2 trials and expects to enter Phase 3 trials soon.
TechoShark seeks to increase the click through rates for mobile ads by mining social network data. The company has an algorithm that uses the multidimensional data available in a social network profile to match a user with appropriate ads. The company, which has received SBIR grant funding, hopes to use this algorithm in its SocialDealz platform to partner with large mobile ad networks. TechoShark has also developed its own iPhone application calledHoozat, a mobile social network in which it hopes to pilot its ad service.
Rivertop Renewables calls itself a “renewable chemical company” and seeks to remove many of the toxic inputs and intermediaries required in the manufacture of a variety of chemicals. Broadly, the company expects to use carbohydrates to produce glucarates at a higher efficiency and lower cost than achievable via other methods. Initially the company is targeting glucaric acid production from glucose with plans to sell into the market for corrosion inhibitors in road de-icers.
HepQuant, founded in 2007, seeks to provide a clinical test for liver function. The test, which would assess portal circulation, would provide much more extensive information than current blood panels but would not be invasive like biopsies. The test results could prove information valuable to hepatologists’ treatment decisions in patients suffering from liver disease. The company has received $500K in research grants and expects it could have a test to market in 2013.
CytoLogic seeks to use a dialysis-like treatment to enhance cancer therapy. Using standard dialysis equipment, a patient’s plasma would be separated and then treated using the proprietary CytoLogic protein developed at CSU, filtering the tumor necrosis factor (TNF) inhibitors out of the blood. With these inhibitors removed, TNF would be more active and generating an enhanced immune response and stimulating the body’s own ability to fight cancer. The treatment could be used alone or in combination with chemotherapeutic agents, for which much lower doses are likely to be effective.
PorousPower creates a unique membrane that can be used as a separator in lithium ion batteries. The higher porosity provided by the company’s Symmetrix membrane generates a number of advantages including greater high power capacity, more cycles, and faster charging. Electric drive vehicles represent a key initial market. PorousPower has its own production line and plans to create modular production units that can be dropped into the existing factories of battery makers.